During day
trading
hours,
there
were
many
stocks
that
continued
to
break
up
to
the
upside.These
stocks
are
usually
going
up
or
down
on
with
news.If
you
are
looking
to
day
trade
today,
you
might
want
to
check
out
the
following
stocks. I
usually
throw
these
on
my
watch
list
and
monitor
with
resistance
&
support
levels.
Below
are a
list
of
stocks
that I
am
watching
for
today.You can also check previous stocks to buy reports- Right Here
Stock Trading Signals's Top #PreMarket Gainers
Pre-open movers
US
stock futures rose in early pre-market trading, ahead of jobless claims data.
Data on international trade for February and weekly jobless claims will be
released at 8:30 a.m. ET. The Markit PMI
services index for March will be released at 9:45
a.m. ET, while the ISM non-manufacturing index for March will be
released at 10:00 a.m. ET. Futures
for the Dow Jones Industrial Average surged 23 points to 16,510.00, while the Standard
& Poor's 500 index futures rose 2 points to 1,884.90. Futures for the
Nasdaq 100 index gained 4 points to 3,662.25.
A Peek Into Global Markets
European markets were mixed today, with the Spanish Ibex
Index gaining 1.02%, London's FTSE
100 index dropping 0.02% and STOXX Europe 600 Index falling 0.06%. German DAX
30 index declined 0.01% and French CAC 40
Index rose 0.02%.
Asian markets ended mixed today. Japan's
Nikkei Stock Average rose 0.84%, Hong Kong's Hang Seng
Index jumped 0.18% and China's
Shanghai Composite Index fell 0.74% and India's
BSE Sensex dropped 0.19%.China's official nonmanufacturing PMI
slipped to 54.5 in March versus 55.0 in February, while the HSBC China services
PMI surged to 51.9 in March versus 51.0 in
February. The HSBC India's Service Sector Business Activity Index declined to
47.5 in March versus 48.8 in February.
Broker Recommendation
Analysts at JP Morgan upgraded Monsanto Company (NYSE: MON) from “neutral” to overweight.” The target price for
Monsanto has been raised from $115 to $125.
Monsanto's shares closed at $114.42 yesterday.
Breaking news
◾ Omeros (NASDAQ: OMER) today announced that its
Investigational New Drug Application (IND)
to evaluate OMS721 for the inhibition of complement mediated thrombotic
microangiopathies (TMAs) has been cleared by the U.S. Food and Drug
Administration (FDA).
◾ Ctrip.com International (NASDAQ: CTRP) today announced
that the board of the Company has approved a new share repurchase program
whereby Ctrip may purchase its own American depositary shares with an aggregate
value of up to US$600 million. .
◾ Tarena International (NASDAQ: TEDU), today announced that
it has priced its initial public offering of 15,300,000 American Depositary
Shares at US$9.00 per ADS, for a total offering size of US$137.7 million,
assuming the underwriters do not exercise their option to purchase additional
ADSs.
◾ Response Genetics (NASDAQ: RGDX) today announced that it
has signed agreements with six additional health plans across 10 states
bringing the Company's total national contracted membership to more than 174
million lives.
For the latest updates on the stock market, visit,
